Nolca Med(SRL)

BE 0794.997.746

	2023		2022
Profit/Loss Section 9904: Profit/Loss of the financial year (after taxes on result) (+/-)	€ 7.875	> 1.000%	€ 61
Equity Section 10/15: Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ 9.936	382%	€ 2.061
Gross margin Section 9900: Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices (70/74 – 60/61). A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ 19.014	> 1.000%	€ 1.026

	Date	Publication
	22-12-2022	Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

What is the enterprise number of Nolca Med?

The enterprise number of Nolca Med is BE0794997746.

When was Nolca Med founded?

Nolca Med was founded on 20-12-2022.

What is the address of Nolca Med?

The current registered office of Nolca Med is located at Faubourg de Namur 82, 1400 Nivelles.

When was the last time Nolca Med filed their annual financial statements?

The most recent financial statements of Nolca Med were filed on 20-07-2024. You can view them here.

How many employees does Nolca Med have?

There are currently no employees working at Nolca Med or no workforce information is available.

What is the annual turnover of Nolca Med?

At the time of its most recent financial statements, Nolca Med did not publish any turnover figures. Nolca Med reported a gross margin of €19,014.42.